This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Measures of Obesity and Co-Morbid Conditions in Maori

This study has been completed.
Information provided by:
Edgar National Centre for Diabetes Research Identifier:
First received: September 13, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted
It has been proposed that a higher cut off for BMI (body mass index) is to be used in Maori to define overweight and obesity. However, no one has assessed the prevalence of co-morbid conditions associated with BMI. It is well known that Maori are at greater risk of diabetes and cardiovascular disease compared to non-Maori and a delay in the identification of those who are overweight and obese may be detrimental for Maori. We will assess BMI, other measures of adiposity and prevalence of co-morbid conditions with a comparison with a similar matched non-Maori population.

Body Composition

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Time Perspective: Prospective

Further study details as provided by Edgar National Centre for Diabetes Research:

Estimated Enrollment: 220
Study Start Date: January 2003
Estimated Study Completion Date: December 2005
Detailed Description:

This is a body composition analysis study of people self-identifying Maori and non-Maori participants from both Dunedin and Invercargill. The study consists of a clinical visit for anthropometry and oral glucose tolerance test (OGTT), followed by a single Dexa Scan visit. Participants meeting all the inclusion criteria were invited to participate in the study.

Outcome will be determined by examining Dexa Scan data and surrogate clinical endpoints. The clinical endpoints include: anthropometric measurements, Dexa analysis, bioelectric impedance, and BP measurements, and the biochemical measures of: lipid profile, fasting insulin and glucose, liver functions and uric acid levels.


Ages Eligible for Study:   18 Years to 68 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Self identify as Maori and non-Maori aged between 18-68 years
  • Male and female
  • Non-diabetic
  • Resident of Dunedin and Invercargill

Exclusion Criteria:

  • The presence of diabetes, renal or liver failure, or any other medical condition which is unstable and for which they are currently having active treatment
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00208598

New Zealand
Edgar National Centre for Diabetes Research
Dunedin, Otago, New Zealand, 9001
Sponsors and Collaborators
Edgar National Centre for Diabetes Research
Study Director: Jim I Mann, FRACP, PhD Edgar National Centre for Diabetes Research
  More Information

Additional Information: Identifier: NCT00208598     History of Changes
Other Study ID Numbers: ENCDR_3
Study First Received: September 13, 2005
Last Updated: September 13, 2005

Keywords provided by Edgar National Centre for Diabetes Research:
Body Composition
Cardiovascular disease
Diabetes processed this record on September 21, 2017